tisagenlecleucel

English

Etymology

From tisa- (unique name) +‎ -gen- (“transfer of genetic material (transduced)”) +‎ -lec- (“selection and enrichment manipulation”) +‎ -leu- (“leukocytes”) +‎ -cel (“cellular therapy”).

Pronunciation

• IPA^(key): /ˌtɪsəd͡ʒɛnləˈkluːsəl/, /ˌtɪsəd͡ʒɛnˈlɛkluːsəl/

Noun

tisagenlecleucel (uncountable)

1. (pharmacology) An anti-CD19 CAR-T cell therapy used in the treatment of haematological malignancies.

See also

• axicabtagene ciloleucel